Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3086354
Max Phase: Preclinical
Molecular Formula: C49H80FN13O13
Molecular Weight: 1078.25
Molecule Type: Unknown
Associated Items:
ID: ALA3086354
Max Phase: Preclinical
Molecular Formula: C49H80FN13O13
Molecular Weight: 1078.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NNC(=O)[C@@H](N)Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2[18F])nn1)C(C)(C)C)C(=O)O
Standard InChI: InChI=1S/C49H80FN13O13/c1-26(2)21-34(48(74)75)56-45(72)40(49(3,4)5)57-43(70)33(22-27-14-16-29(65)17-15-27)55-44(71)35-13-10-20-62(35)46(73)32(12-7-9-19-52)54-42(69)31(11-6-8-18-51)59-60-41(68)30(53)23-28-24-63(61-58-28)47-37(50)39(67)38(66)36(25-64)76-47/h14-17,24,26,30-40,47,59,64-67H,6-13,18-23,25,51-53H2,1-5H3,(H,54,69)(H,55,71)(H,56,72)(H,57,70)(H,60,68)(H,74,75)/t30-,31-,32-,33-,34-,35-,36+,37+,38+,39+,40+,47+/m0/s1/i50-1
Standard InChI Key: MDDPXKZMRLVQMQ-CGQMVZIESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1078.25 | Molecular Weight (Monoisotopic): 1077.5983 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lang C, Maschauer S, Hübner H, Gmeiner P, Prante O.. (2013) Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors., 56 (22): [PMID:24160350] [10.1021/jm401491e] |
Source(1):